TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Control Bionics Ltd. ( (AU:CBL) ) is now available.
Control Bionics Ltd has announced the appointment of Stephen Rix as a director, effective December 1, 2025. Rix holds 100,000 ordinary shares directly and has an indirect interest in 5,634,215 ordinary shares through Windward Capital Pty Limited. This appointment and the associated shareholdings could influence the company’s strategic direction and stakeholder interests.
The most recent analyst rating on (AU:CBL) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Control Bionics Ltd. stock, see the AU:CBL Stock Forecast page.
More about Control Bionics Ltd.
Control Bionics Ltd operates in the technology industry, focusing on developing assistive communication devices. The company specializes in creating products that enable individuals with disabilities to communicate and interact with their environment, enhancing their quality of life and independence.
Average Trading Volume: 1,062,519
Technical Sentiment Signal: Buy
Current Market Cap: A$24.04M
Learn more about CBL stock on TipRanks’ Stock Analysis page.